Alkermes (ALKS) Total Liabilities (2011 - 2026)
Alkermes (ALKS) posted quarterly Total Liabilities of $2.6 billion for Q2 2026, up 311.41% year-over-year from $628.2 million in Q2 2025, and up 3.11% quarter-over-quarter from $2.5 billion in Q1 2026.
Alkermes (ALKS) Total Liabilities (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Total Liabilities for 16 consecutive years, with $2.6 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities rose 311.41% year-over-year to $2.6 billion; the TTM figure through Jun 2026 stood at $2.6 billion (up 311.41% YoY), while the FY2025 annual figure was $667.7 million, up 13.06% from the prior year.
- Total Liabilities grew to $2.6 billion in Q2 2026 per ALKS's latest filing, from $2.5 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $2.6 billion in Q2 2026 and bottomed at $570.4 million in Q1 2025.
- Historically, Total Liabilities has averaged $1.0 billion across 5 years, with a median of $900.8 million in 2022.
- Annual changes were most pronounced in 2024 — Total Liabilities sank 36.74% — and 2026, when it jumped 339.44%.
- Alkermes' Total Liabilities stood at $920.2 million in 2022, then increased by 1.45% to $933.5 million in 2023, then tumbled by 36.74% to $590.6 million in 2024, then gained by 13.06% to $667.7 million in 2025, then jumped by 287.09% to $2.6 billion in 2026.
- Business Quant data shows ALKS's Total Liabilities at $2.6 billion in Q2 2026, $2.5 billion in Q1 2026, and $667.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 2.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Bn |
| Mar 31, 2026 | 2.51 Bn |
| Dec 31, 2025 | 667.70 Mn |
| Sep 30, 2025 | 596.08 Mn |
| Jun 30, 2025 | 628.23 Mn |
| Mar 31, 2025 | 570.39 Mn |
| Dec 31, 2024 | 590.59 Mn |
| Sep 30, 2024 | 863.19 Mn |
| Jun 30, 2024 | 922.84 Mn |
| Mar 31, 2024 | 869.13 Mn |
| Dec 31, 2023 | 933.54 Mn |
| Sep 30, 2023 | 923.65 Mn |
| Jun 30, 2023 | 906.75 Mn |
| Mar 31, 2023 | 917.15 Mn |
| Dec 31, 2022 | 920.23 Mn |
| Sep 30, 2022 | 899.05 Mn |
| Jun 30, 2022 | 875.09 Mn |
| Mar 31, 2022 | 902.46 Mn |
| Dec 31, 2021 | 911.90 Mn |
| Sep 30, 2021 | 899.26 Mn |